Simone Gambazza
@simonegambazza.bsky.social
Post-Doc Research Fellow at University of Milan 🇮🇹 Statistician for the European Cystic Fibrosis Patient Registry
Heterogeneous use of multiple breath washout in cystic fibrosis across age groups and European countries.
www.cysticfibrosisjournal.com/article/S156...
www.cysticfibrosisjournal.com/article/S156...
Heterogeneous use of multiple breath washout in cystic fibrosis across age groups and European countries: an ECFSPR analysis
In cystic fibrosis (CF) lung health declines throughout life due to damaging cycles
of infection and inflammation, and normal aging [1]. Many adults with CF with “milder”
genotypes and children with C...
www.cysticfibrosisjournal.com
December 9, 2025 at 8:32 PM
Heterogeneous use of multiple breath washout in cystic fibrosis across age groups and European countries.
www.cysticfibrosisjournal.com/article/S156...
www.cysticfibrosisjournal.com/article/S156...
Use of chronic inhaled antibiotics for non-chronic Pseudomonas aeruginosa remained unchanged ∼22 % between 2011 and 2019 in European people with Cystic Fibrosis
Read more about 📚
www.sciencedirect.com/science/arti...
Read more about 📚
www.sciencedirect.com/science/arti...
Changes in use of inhaled chronic antibiotics in the European CF population: an ECFS patient registry study
Improved outcomes of people with CF (pwCF) in the last decade require reconsidering prescriptions of chronic inhaled antibiotics (iAB). We compared iA…
www.sciencedirect.com
November 25, 2025 at 6:18 PM
Use of chronic inhaled antibiotics for non-chronic Pseudomonas aeruginosa remained unchanged ∼22 % between 2011 and 2019 in European people with Cystic Fibrosis
Read more about 📚
www.sciencedirect.com/science/arti...
Read more about 📚
www.sciencedirect.com/science/arti...
Even with Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy, physical exercise training remains a key and effective means of improving physical fitness in people with Cystic Fibrosis (pwCF).
www.cysticfibrosisjournal.com/article/S156...
www.cysticfibrosisjournal.com/article/S156...
Limited impact of Elexacaftor/Tezacaftor/Ivacaftor on CPET outcomes in an Italian cohort of people with Cystic Fibrosis: reinforcing the essential role of exercise training
Disease burden and long-term complications of people with Cystic Fibrosis (pwCF) are
evolving as the number of subjects taking advantage of highly effective CF Transmembrane
conductance Regulator (CFT...
www.cysticfibrosisjournal.com
October 18, 2025 at 3:08 PM
Even with Elexacaftor/Tezacaftor/Ivacaftor (ETI) therapy, physical exercise training remains a key and effective means of improving physical fitness in people with Cystic Fibrosis (pwCF).
www.cysticfibrosisjournal.com/article/S156...
www.cysticfibrosisjournal.com/article/S156...
Improvements in lung function and nutritional status were comparable, regardless of Pseudomomas aeruginosa status, in people with #cysticFibrosis on #ETI therapy.
📚Read our latest work on 8188 people with #CF.
www.sciencedirect.com/science/arti...
📚Read our latest work on 8188 people with #CF.
www.sciencedirect.com/science/arti...
Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry
Elexacaftor/tezacaftor/ivacaftor (ETI) therapy reduces airway infection rates with Pseudomonas aeruginosa (PsA). This study assessed factors associate…
www.sciencedirect.com
September 11, 2025 at 5:51 AM
Improvements in lung function and nutritional status were comparable, regardless of Pseudomomas aeruginosa status, in people with #cysticFibrosis on #ETI therapy.
📚Read our latest work on 8188 people with #CF.
www.sciencedirect.com/science/arti...
📚Read our latest work on 8188 people with #CF.
www.sciencedirect.com/science/arti...